Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05009537 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optical Genome Mapping in Hematological Malignancies

Study acronym: CARTOGEN
StatusUnknown
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 17, 2021 (before its estimated September 2022 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Aug 2021); last known: Recruiting
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer
Trial Details
NCT Number NCT05009537
Lead Sponsor University Hospital, Brest
Conditions
(from sponsor)		 MDS, ALL, Other Hematologic Malignant Neoplasms
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov